Suppr超能文献

在一家三级保健中心的甲状腺病变细针抽吸细胞学检查中甲状腺恶性肿瘤的研究。

Thyroid Malignancy among Fine Needle Aspiration Cytology of Thyroid Lesions in a Tertiary Care Centre.

机构信息

Department of Pathology, Shree Birendra Hospital, Chhauni, Kathmandu, Nepal.

Department of Pathology, Bhaktapur Hospital, Dudhpati, Bhaktapur, Nepal.

出版信息

JNMA J Nepal Med Assoc. 2024 Jan 2;62(269):21-23. doi: 10.31729/jnma.8396.

Abstract

INTRODUCTION

The most prevalent endocrine cancer in the world is thyroid cancer, and its incidence is on the rise. The distinction between benign and malignant thyroid nodules must be made, which is why fine needle aspiration cytology of thyroid lesion is necessary and required. This study aimed to find out the prevalence of thyroid malignancy among fine needle aspiration cytology of thyroid lesions in a tertiary care centre.

METHODS

A descriptive cross-sectional study was conducted among fine needle aspiration cytology of thyroid lesions in a tertiary care centre after obtaining ethical approval from the Institutional Review Committee. Data from 13 April 2020 to 13 April 2023 was collected between 19 May 2023 to 19 June 2023. All the patients with complete hospital record data were included in this study. However, repetitive fine needle aspiration cytology of thyroid lesion were excluded from the study. Fine needle aspiration cytology diagnoses were categorized in this study as per the Bethesda system for reporting thyroid cytopathology. The point estimate was calculated at a 95% Confidence Interval.

RESULTS

Among 398 fine needle aspiration cytology of thyroid lesions, thyroid malignancy was seen in 12 (3.02%) (1.34-4.70, 95% Confidence Interval) patients.

CONCLUSIONS

The prevalence of thyroid malignancy was found to be lower than other studies done in similar settings.

KEYWORDS

cytology; malignancy; prevalence; thyroid.

摘要

介绍

甲状腺癌是世界上最常见的内分泌癌,其发病率呈上升趋势。必须区分甲状腺良恶性结节,这就是为什么需要进行甲状腺病变细针穿刺细胞学检查。本研究旨在探讨三级保健中心甲状腺病变细针穿刺细胞学检查中甲状腺恶性肿瘤的患病率。

方法

本研究为描述性横断面研究,在获得机构审查委员会的伦理批准后,在三级保健中心进行甲状腺病变细针穿刺细胞学检查。数据收集时间为 2020 年 4 月 13 日至 2023 年 4 月 13 日,2023 年 5 月 19 日至 6 月 19 日进行数据分析。本研究纳入了所有完整的医院记录数据的患者。然而,重复性甲状腺病变细针穿刺细胞学检查被排除在研究之外。本研究按照甲状腺细胞病理学报告的 Bethesda 系统对细针穿刺细胞学诊断进行分类。点估计值在 95%置信区间内计算。

结果

在 398 例甲状腺病变细针穿刺细胞学检查中,有 12 例(3.02%)(95%置信区间为 1.34-4.70)患者发现甲状腺恶性肿瘤。

结论

与类似环境下进行的其他研究相比,本研究发现甲状腺恶性肿瘤的患病率较低。

关键词

细胞学;恶性肿瘤;患病率;甲状腺

相似文献

1
Thyroid Malignancy among Fine Needle Aspiration Cytology of Thyroid Lesions in a Tertiary Care Centre.
JNMA J Nepal Med Assoc. 2024 Jan 2;62(269):21-23. doi: 10.31729/jnma.8396.
3
Ultrasound Parameters of Thyroid Nodules and the Risk of Malignancy: A Retrospective Analysis.
Cancer Control. 2020 Jan-Dec;27(1):1073274820945976. doi: 10.1177/1073274820945976.
6

引用本文的文献

本文引用的文献

1
The prevalence and associated predictors for Bethesda III-VI for reporting thyroid cytopathology in Royal Commission Hospital, Kingdom of Saudi Arabia.
Ther Adv Endocrinol Metab. 2022 Sep 12;13:20420188221122486. doi: 10.1177/20420188221122486. eCollection 2022.
2
Study of incidence of malignancy in clinically benign thyroid swelling.
South Asian J Cancer. 2015 Jul-Sep;4(3):151-3. doi: 10.4103/2278-330X.173166.
4
Thyroid disorders in India: An epidemiological perspective.
Indian J Endocrinol Metab. 2011 Jul;15(Suppl 2):S78-81. doi: 10.4103/2230-8210.83329.
5
Thyroid cancer gender disparity.
Future Oncol. 2010 Nov;6(11):1771-9. doi: 10.2217/fon.10.127.
6
The Bethesda System For Reporting Thyroid Cytopathology.
Am J Clin Pathol. 2009 Nov;132(5):658-65. doi: 10.1309/AJCPPHLWMI3JV4LA.
7
Thyroid fine-needle aspiration biopsy: variability in reporting.
Thyroid. 2009 Jul;19(7):717-23. doi: 10.1089/thy.2008.0425.
8
Thyroid aspiration cytology: current status.
CA Cancer J Clin. 2009 Mar-Apr;59(2):99-110. doi: 10.3322/caac.20014.
9
Thyroid nodules - stepwise diagnosis and management.
Hormones (Athens). 2007 Apr-Jun;6(2):101-19. doi: 10.14310/horm.2002.111107.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验